IDH1 and glioblastoma: Given that IDH-wildtype and IDH-mutant GBM are regarded as distinct entities despite their similar histology (11), further stratification of patients with IDH-mutant or IDH-wildtype GBM could be a promising approach for the diagnosis and treatment of GBM.